Breaking #Psilocybin #Stock News: Kaya
Holdings (OTCQB: $KAYS) Unveils "The Scared Mushroom(TM)", the First
US-Based Psilocybin Center to be Operated by a US Public Company; @KayaHoldings
FT.
LAUDERDALE, FL - November 7, 2023 (Investorideas.com Newswire) Kaya Holdings,
Inc., ("KAYS" or the "Company") (OTCQB:KAYS) has shared the company's progress to open "The
Sacred Mushroom™" Psilocybin Facilitation Center in Portland, Oregon and
invites interested parties to view the project presentation.
Read this
news, featuring KAYS in full at https://www.investorideas.com/CO/KAYS/news/2023/11071The-Scared-Mushroom.asp
The Sacred Mushroom™ has
approximately 11,000 sq ft. and will provide visitors with access to many
distinctive treatment experiences including private treatment rooms and group
session areas, activity zones with yoga, listening stations, journaling chairs,
and art expression, special "sensation rooms", and a special approach
to microdosing.
To read and download the report click
the following link:
KAYS
SHAREHOLDERS AND OTHER INTERESTED PARTIES - PLEASE UPDATE YOUR CONTACT
INFORMATION
We routinely receive calls and emails from
shareholders asking us questions about KAYS, so we are asking all KAYS
shareholders to email us and confirm their contact info. Please email
info@kayaholdings.com with "KAYS shareholder update" in the subject
line and include your name, address, phone number and number of shares you own
so that we may make sure you receive all updates and can respond to any
shareholder inquiries. If you would like to speak to someone at the Company,
please call ore text 954-480-3960 and someone will get right back to you.
About
Kaya Holdings, Inc. (www.kayaholdings.com)
Kaya Holdings, Inc is a
"mind care" company with operations in medical/recreational cannabis
and pending operations in the emerging psilocybin sector. KAYS is a fully
reporting, US-based publicly traded company, listed for trading on the
over-the-counter market under the symbol KAYS.
In 2014 KAYS became the first US
public company to own and operate a medical cannabis dispensary (in Portland,
Oregon). The Company still operates the original Kaya Shack™ cannabis
dispensary while seeking to shift our cannabis operations to serve the European
Union. KAYS has interests in three medical cannabis licenses (2 in Greece, 1 in
Israel) to advance this effort.
Resuming its role as innovator and trend setter, the
Company is again breaking ground in the United States with the planned
introduction of psilocybin treatment centers through our majority owned
subsidiary, Fifth Dimension Therapeutics, Inc. ("FDT").
KAYS subsidiaries include:
Fifth
Dimension Therapeutics, Inc.
serves as the Company's operating branch in the psychedelic treatment sector,
including operation of mushroom cultivation facilities and The Scared Mushroom™
treatment centers.
Marijuana
Holdings Americas, Inc. owns the
Kaya Shack™ brand of licensed medical and recreational marijuana stores (www.kayashack.com)
and the Kaya Farms™ brand of cannabis production and processing operations in
the United States.
Kaya
Brands International, Inc.,
serves as the vehicle for the Company's non-U.S. operations including
cultivation activities under development in Greece and Israel.
Kaya
Brands USA, Inc. owns a wide range of
proprietary brands of cannabis extracts, oils, pre-rolls, topicals, edibles and
beverages, cannaceuticals and related accessories.
Important
Disclosure
KAYS is planning execution of its
stated business objectives in accordance with current understanding of state
and local laws and federal enforcement policies and priorities as it relates to
psychedelics and cannabis. Potential investors and shareholders are cautioned
that KAYS and subsidiaries including FDT will obtain advice of counsel prior to
actualizing any portion of their business plan (including but not limited to
license applications for the cultivation, distribution or sale of marijuana and
psychedelic products, engaging in said activities or acquiring existing
production/sales operations). Advice of counsel with regard to specific
activities of KAYS, federal, state or local legal action or changes in federal
government policy and/or state and local laws may adversely affect business
operations and shareholder value. Additionally, the launch of The Sacred
Mushroom™ Psilocybin Treatment Center is dependent, among other matters, on
final Oregon Health Authority ("OHA") licensing and receipt of final
financing from our investors.
Forward-Looking
Statements
This press release includes
statements that may constitute "forward-looking" statements, usually
containing the words "believe," "estimate,"
"project," "expect" or similar statements are made pursuant
to the safe harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements inherently involve risks and uncertainties
that could cause actual results to differ materially from the forward-looking
statements. Factors that would cause or contribute to such differences include,
but are not limited to, acceptance of the Company's current and future products
and services in the marketplace, the ability of the Company to develop
effective new products and receive regulatory approvals of such products,
competitive factors, dependence upon third-party vendors, and other risks
detailed in the Company's periodic report filings with the Securities and
Exchange Commission. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions or changes
after the date of this release.
SOURCE: Kaya Holdings
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investing involves risk and possible losses. This site is currently compensated
for news publication and distribution, social media and marketing, content
creation and more. Disclosure: this news content featuring Kaya Holdings, Inc.
(OTCQB:KAYS) is paid for content . Learn more Contact management and IR of each company directly
regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your
news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/ Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Kaya
Holdings, Inc. (OTCQB: KAYS) is a featured Cannabis stock on Investorideas.com Visit
profile page
Get News Alerts on KAYA
Holdings (KAYS)
